Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Body mass index |
Body mass index |
at pre transplant |
|
Primary |
Body mass index |
Body mass index |
at Day 0 |
|
Primary |
Body mass index |
Body mass index |
at Day 30 |
|
Primary |
Body mass index |
Body mass index |
at Day 100 |
|
Primary |
Body mass index |
Body mass index |
at Day 300 |
|
Primary |
visual analogic scale of appetite |
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption. Score from 1 to 10. There are not better or worse values. |
at pre transplant |
|
Primary |
visual analogic scale of appetite |
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption. Score from 1 to 10. There are not better or worse values |
at Day 0 |
|
Primary |
visual analogic scale of appetite |
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption. Score from 1 to 10. There are not better or worse values |
at Day 30 |
|
Primary |
visual analogic scale of appetite |
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption. Score from 1 to 10. There are not better or worse values |
at Day 100 |
|
Primary |
visual analogic scale of appetite |
It allows a visual assessment, by the patient himself, of his food intake, using an analog scale, or a choice of portions consumed.Visual analog scales (VAS) are reliable tools to evaluate hunger and satiety at point of food consumption. Score from 1 to 10. There are not better or worse values |
at Day 300 |
|
Primary |
sit up test |
sit up test |
at pre transplant |
|
Primary |
sit up test |
sit up test |
at Day 0 |
|
Primary |
sit up test |
sit up test |
at Day 30 |
|
Primary |
sit up test |
sit up test |
at Day 100 |
|
Primary |
sit up test |
sit up test |
at Day 300 |
|
Primary |
bio electrical impedance analysis, |
it's measuring the resistance of biological tissues |
at pre transplant |
|
Primary |
bio electrical impedance analysis, |
it's measuring the resistance of biological tissues |
at Day 0 |
|
Primary |
bio electrical impedance analysis, |
it's measuring the resistance of biological tissues |
at Day 30 |
|
Primary |
bio electrical impedance analysis, |
it's measuring the resistance of biological tissues |
at Day 100 |
|
Primary |
bio electrical impedance analysis, |
it's measuring the resistance of biological tissues |
at Day 300 |
|
Primary |
hand grip |
hand grip |
at pre transplant |
|
Primary |
hand grip |
hand grip |
at Day 0 |
|
Primary |
hand grip |
hand grip |
at Day 30 |
|
Primary |
hand grip |
hand grip |
at Day 100 |
|
Primary |
hand grip |
hand grip |
at Day 300 |
|
Secondary |
Quality of life assessment, |
it's a satisfaction patient's scale |
at pre transplant |
|
Secondary |
Quality of life assessment, |
it's a satisfaction patient's scale |
at Day 0 |
|
Secondary |
Quality of life assessment, |
it's a satisfaction patient's scale |
at Day 30 |
|
Secondary |
Quality of life assessment, |
it's a satisfaction patient's scale |
at Day 100 |
|
Secondary |
Quality of life assessment, |
it's a satisfaction patient's scale |
at Day 300 |
|
Secondary |
number of infections, |
number of infections, |
at pre transplant |
|
Secondary |
number of infections, |
number of infections, |
at Day 0 |
|
Secondary |
number of infections, |
number of infections, |
at Day 30 |
|
Secondary |
number of infections, |
number of infections, |
at Day 100 |
|
Secondary |
number of infections, |
number of infections, |
at Day 300 |
|
Secondary |
number of graft versus host disease, |
number of graft versus host disease, |
at pre transplant |
|
Secondary |
number of graft versus host disease, |
number of graft versus host disease, |
at Day 0 |
|
Secondary |
number of graft versus host disease, |
number of graft versus host disease, |
at Day 30 |
|
Secondary |
number of graft versus host disease, |
number of graft versus host disease, |
at Day 100 |
|
Secondary |
number of graft versus host disease, |
number of graft versus host disease, |
at Day 300 |
|
Secondary |
overall survival |
overall survival |
at pre transplant |
|
Secondary |
overall survival |
overall survival |
at Day 0 |
|
Secondary |
overall survival |
overall survival |
at Day 30 |
|
Secondary |
overall survival |
overall survival |
at Day 100 |
|
Secondary |
overall survival |
overall survival |
at Day 300 |
|